<DOC>
	<DOCNO>NCT02389998</DOCNO>
	<brief_summary>This study aim investigate efficacy placebo symptom relief child abdominal pain related functional gastrointestinal disorder .</brief_summary>
	<brief_title>Efficacy Open Label Placebo Children With FGIDs</brief_title>
	<detailed_description>The purpose research study see prescribe open label placebo child functional gastrointestinal disorder help improve symptom overall quality life . Open label mean you/your child aware take liquid placebo drop active medication . Symptoms associate functional gastrointestinal disorder ( FGIDs ) child adolescents commonly encounter symptom general pediatrics pediatric gastroenterology . The FGIDs investigator study include functional abdominal pain , irritable bowel syndrome , functional dyspepsia . The liquid placebo drop contain active medication . Recent research study show improvement gastrointestinal symptom take liquid placebo drop child adult FGIDs . A randomize research study medication use treat child FGIDs show significant placebo effect , mean patient receive placebo also experience improvement symptom . Randomized refers fact subject randomly select receive either study medication placebo . A recent adult study give adult patient placebo told placebo , adult also significant symptom improvement . The goal study explore use open label ( non-deceptive ) placebo use treat child FGIDs .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Hyoscyamine</mesh_term>
	<criteria>1 . Age 8 21 year . 2 . Diagnosis functional abdominal pain , irritable bowel syndrome functional dyspepsia make pediatric gastroenterologist accord Rome III Criteria . 3 . Mean daily intensity pain 25 mm week prior initiation study , base WordGraphic Rating Scale score . 4 . Children exclude adhere specific diet . Children ask report specific establish diet prior study dietary modification could make course study . 5 . Normal laboratory test include complete blood count , erythrocyte sedimentation rate , albumin , serum amylase , lipase , liver enzymes , urine analysis , stool examination occult blood ovum parasites one month prior initiation study . Urinary culture obtain symptom urinalysis suggest possibility urinary infection . 6 . Normal lactose breath test history lack resolution symptom lactosefree diet ( 2 week ) . 7 . Patients receive psychological treatment , hypnosis , biofeedback guide imagery exclude study start least one month prior initiation study plan discontinue length trial . Patients need prescribe hyoscyamine ( clinically indicate ) consider study , placebo addition prescribe medication . 1 . Inclusion criterion meet . 2 . Evidence organic gastrointestinal disease , hepatic disorder , urinary cardiac disease . 3 . Children 5th percentile weight height . 4 . Hemoccult positive stool . 5 . Patients diagnosis Inflammatory Bowel Disease , hyperthyroidism , CHF , cardiac arrhythmia , prostatic hypertrophy , autonomic neuropathy , biliary tract disease , child spastic paralysis chronic lung disease ( consult pulmonologist concern inclusion child chronic lung disease ) . 6 . Patients take follow drug : AbobotulinumtoxinA , Acetylcholinesterase Inhibitors ( Central ) , Cannabinoids , OnabotulinumtoxinA , Potassium Chloride , Pramlintide , RimabotulinumtoxinB , Secretin . Patients receive antidepressant anticholinergic drug exclude study . PPIs allow long patient stable dose least 12 week . 7 . Patients plan change diet time study exclude . Children ask report specific establish diet prior study dietary modification could make course study . 8 . Patients plan start psychological treatment , hypnosis , biofeedback , guide imagery course study start within month prior consent . 9 . The participant pregnant planning become pregnant throughout course research study</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Functional Pain</keyword>
	<keyword>Abdominal Pain</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>IBS</keyword>
	<keyword>Functional Dyspepsia</keyword>
	<keyword>FGID</keyword>
	<keyword>Functional Gastrointestinal Disorders</keyword>
</DOC>